in

Early Stage Venture BioShin Raises Series A of $60000000

About BioShin

BioShin is a clinical-stage biopharmaceutical company focused on developing medicines for the Asia-Pacific region.

Website: Learn more on BioShin’s website

Crunchbase: Follow on Crunchbase

Series A – BioShin

Amount Raised60000000 USD
Announced Date2020-09-28
Equity Only FundingYes
Organization LocationShanghai, Shanghai, China, Asia
Funding StatusEarly Stage Venture
Number of Funding Rounds1
Lead InvestorsOrbiMed
Number of Investors5
Number of Partner Investors1

Written by Startup News

Early Stage Venture Fiture Raises Series A of $65000000

Early Stage Venture Shiok Meats Raises Series A of $12600000